Intangible Assets

A reconciliation of the activity affecting intangible assets is as follows:



(In thousands)	Indefinite Lived Trademarks		Finite Lived Trademarks			Totals
Gross Carrying Amounts
Balance — March 31, 2014	$	1,273,878	$	204,740		$	1,478,618
Additions	73,580		—			73,580
Reductions	—		—			—
Effects of foreign currency exchange rates	1,981		29			2,010
Balance — June 30, 2014	1,349,439		204,769			1,554,208

Accumulated Amortization
Balance — March 31, 2014	—		83,801			83,801
Additions	—		2,237			2,237
Reductions	—		—			—
Effects of foreign currency exchange rates	—		(2		)	(2		)
Balance — June 30, 2014	—		86,036			86,036

Intangible assets, net - June 30, 2014	$	1,349,439	$	118,733		$	1,468,172

Intangible Assets, net by Reportable Segment:
North American OTC Healthcare	$	1,123,898	$	91,407		$	1,215,305
International OTC Healthcare	105,721		1,596			107,317
Household Cleaning	119,820		25,730			145,550
Intangible assets, net - June 30, 2014	$	1,349,439	$	118,733		$	1,468,172

As discussed in Note 2, on April 30, 2014, we completed the acquisition of the Hydralyte brand. In connection with this acquisition, we allocated $73.6 million to intangible assets based on our preliminary analysis.

Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount. Additionally, at each reporting period an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life. Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value.

On an annual basis during the fourth fiscal quarter of each year, or more frequently if conditions indicate that the carrying value of the asset may not be recovered, management performs a review of both the values and, if applicable, useful lives assigned to intangible assets and tests for impairment.

In a manner similar to goodwill, we completed our annual test for impairment of our indefinite-lived intangible assets during the three months ended March 31, 2014. We did not record an impairment charge, as facts and circumstances indicated that the fair values of the intangible assets for our brands exceeded their carrying values. Additionally, for the indefinite-lived intangible assets, an evaluation of the facts and circumstances as of June 30, 2014 continues to support an indefinite useful life for these assets. Therefore, no impairment charge was recorded for the three months ended June 30, 2014.

The weighted average remaining life for finite-lived intangible assets at June 30, 2014 was approximately 13.3 years, and the amortization expense for the three months ended June 30, 2014 was $2.2 million. At June 30, 2014, finite-lived intangible assets are being amortized over a period of 3 to 30 years, and the associated amortization expense is expected to be as follows:



(In thousands)
Year Ending March 31,	Amount
2015 (Remaining nine months ending March 31, 2015)	$	6,715
2016	8,953
2017	8,953
2018	8,953
2019	8,953
Thereafter	76,206
	$	118,733